Percheron Therapeutics Ltd
AWY0
Company Profile
Business description
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Contact
35 Collins Street
Level 30, Collins Place
MelbourneVIC3000
AUST: +61 398278999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
8
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
stocks
Tesla earnings: Shares fall as market focuses on uncertainty in near term
Are shares overpriced despite the fall?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,322.60 | 21.10 | -0.23% |
| CAC 40 | 8,225.78 | 18.91 | 0.23% |
| DAX 40 | 24,207.79 | 56.66 | 0.23% |
| Dow JONES (US) | 46,734.61 | 144.20 | 0.31% |
| FTSE 100 | 9,578.57 | 63.57 | 0.67% |
| HKSE | 26,081.53 | 113.55 | 0.44% |
| NASDAQ | 22,941.80 | 201.40 | 0.89% |
| Nikkei 225 | 49,374.09 | 732.48 | 1.51% |
| NZX 50 Index | 13,411.38 | 34.28 | 0.26% |
| S&P 500 | 6,738.44 | 39.04 | 0.58% |
| S&P/ASX 200 | 9,023.90 | 20.30 | -0.22% |
| SSE Composite Index | 3,938.98 | 16.57 | 0.42% |